Epidemiology of focal and generalized dystonia in Rochester, Minnesota
β Scribed by Dr. John G. Nutt; Manfred D. Muenter; Arnold Aronson; Leonard T. Kurland; L. Joseph Melton III
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 470 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
The epidemiology of generalized and focal dystonias was investigated in the Rochester, Minnesota, population over the period 1950-1982. The crude incidence of generalized dystonia was 2 per million persons per year, and for all focal dystonias combined, 24 per million per year. The crude prevalence rate was 34 per million persons for generalized dystonia and 295 per million persons for all focal dystonias. Torticollis was the most common focal dystonia; essential blepharospasm, oromandibular dystonia, spasmodic dysphonia, and writer's cramp were less common and had roughly equal incidence and prevalence rates.
π SIMILAR VOLUMES
The incidence of Reiter's syndrome in a predominantly white, community-based population is reported. The age-adjusted annual incidence rate for males younger than age 50 was 3.5 per 100,000. No female cases were identified. Over time, a greater proportion of cases have been identified among younger
## Abstract The objective of this study was to assess quality of life (QoL) in a communityβbased sample of people with various forms of dystonia and to identify the factors that predict QoL in dystonia. QoL was assessed using two generic questionnaires: the Medical Outcomes Study ShortβForm 36 (SF3
To describe trends in the epidemiology of rheumatoid arthritis (RA) over a period of 30 years in a population-based cohort. Methods. An inception cohort of Rochester, Minnesota residents who were >35 years of age and had RA (as defined by the 1987 American College of Rheumatology criteria for RA) f
## Abstract An increaseing number of neurodegenerative diseases seem to be associated with or even due to disturbancs of cerebral energy metabolism. One generally accepted example is complex I deficiency in substantia nigra from patients with Parkinson's disease. Reports on a complex I defect in pl